Graphite Capital Acquires Independence Products Limited (IPL)
October 28, 2024
Graphite Capital has acquired Independence Products Limited (IPL), a UK-based distributor of prescription infection-prevention products focused on patients with chronic renal conditions. IPL holds a Dispensing Appliance Contractor (DAC) licence, distributes from a Nottingham warehouse and derives the majority of orders from repeat prescriptions, positioning the business to benefit from a growing chronic care patient population.
- Buyers
- Graphite Capital
- Targets
- Independence Products Limited (IPL)
- Industry
- Medical Devices
- Location
- Nottinghamshire, United Kingdom
- Transaction Type
- Buyout
Explore More
Related Acquisitions
-
Inland Pipe Rehabilitation (IPR) Acquires Granite Inliner
March 16, 2022
Infrastructure
Inland Pipe Rehabilitation (IPR), a portfolio company of J.F. Lehman & Company, has completed the acquisition of Granite Inliner and affiliated companies from Granite Construction Incorporated. The add-on expands IPR's trenchless pipe rehabilitation capabilities (CIPP, UV-cured liners, geopolymer solutions and manhole renewal), adds manufacturing and R&D capabilities, and broadens the combined company's geographic presence across North America.
-
Platinum Equity Acquires Controlling Stake in Inventia Healthcare
August 29, 2024
Pharmaceuticals
Platinum Equity has acquired a controlling stake in Inventia Healthcare Limited's core Oral Solid Dosage (OSD) business from India Life Sciences Fund III (advised by InvAscent), NYLIM Jacob Ballas India Fund III and affiliates of the founding Shah family, with the Shah family retaining a minority stake. Headquartered in Mumbai, Inventia is a U.S. FDA- and MHRA-accredited contract manufacturer and developer of generic OSD products serving more than 100 customers across 40+ countries; Platinum plans to expand the business organically and via add-on acquisitions.
-
The Riverside Company Invests in Independent Living Specialists (ILS)
April 6, 2020
Healthcare Services
The Riverside Company has made a growth investment in Independent Living Specialists (ILS), a Sydney-based retailer and distributor of mobility and homecare products. Riverside said the capital will support ILS's national expansion—both organically and via bolt-on acquisitions—and accelerate growth of its retail showrooms, clinically trained field force and online channels.
-
Inflexion Partnership Capital Invests £434m in GlobalData's Healthcare Business
December 1, 2023
Data & Analytics
Inflexion's Partnership Capital has agreed to make a £434 million minority equity investment to carve out GlobalData Plc's Healthcare division as a standalone business in a deal valuing the unit at £1.1 billion. GlobalData will retain majority ownership while partnering with Inflexion to accelerate organic growth, product and content investment, cross-selling, and selective M&A.
-
ECI Partners Acquires Independent Governance Group (IGG)
October 30, 2024
Professional Services
ECI Partners has acquired Independent Governance Group (IGG), the UK provider of professional pensions trusteeship and governance services; LDC has exited its majority stake but has reinvested alongside ECI. Crescent Capital's European Specialty Lending strategy led the debt financing to support the transaction. IGG employs more than 200 people, serves 386 pension schemes with around £324bn of assets and will pursue further organic growth and acquisitions under ECI's ownership.
-
Keensight Capital Acquires Inke from Neuraxpharm
May 1, 2023
Pharmaceuticals
Keensight Capital has signed a binding agreement to acquire Inke, a Spain-based specialist developer and manufacturer of inhalation active pharmaceutical ingredients (APIs), from Neuraxpharm Group; financial terms were not disclosed and the deal is expected to close in May 2023. Neuraxpharm divested Inke to sharpen its focus on CNS therapies, while Keensight will support Inke's management team to expand its footprint, broaden its offering and grow its product portfolio.
Track M&A activity that matters to you
Get real-time deal alerts, build buyer lists with AI, and access our full acquisition database. Start your free trial today.